Navigation Links
NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
Date:6/9/2009

More than 100 Personal Declarations from Employees Nationwide Support Filing

INDIANAPOLIS, June 9 /PRNewswire/ -- The NAACP and nine class representatives today filed a motion for class certification in the United States District Court for the Southern District of Indiana, Indianapolis Division, on behalf of a nationwide group of current and former employees of Eli Lilly Company. At the same time, the plaintiffs filed an amended complaint alleging that the pharmaceutical giant discriminates against its African-American employees in pay, promotion and related promotional opportunities and that Lilly's discriminatory policies and practices deny these African Americans an equal opportunity to advance in their careers.

Accompanying the class certification motion and amended complaint were certified declarations by more than 100 members of the class throughout the United States regarding their adverse employment experiences at the company.

The legal actions were announced at 11 a.m. Tuesday on the steps of the U.S. District Courthouse in Indianapolis by Angela Ciccolo, National General Counsel of the NAACP; plaintiffs' spokesperson Cassandra Welch; and the plaintiffs' attorney and new Co-lead Counsel David Sanford, of Sanford Wittels & Heisler LLP.

Sanford Wittels & Heisler, a national civil rights firm with offices in Washington, D.C., New York City and San Francisco, and the Morelli Ratner firm, a New York City-based plaintiff's firm have joined with Rose & Rose, a civil rights firm in Washington, DC, as Co-lead Counsel in the matter. The plaintiff's local counsel in Indiana is Rob Dassow of Hovde, Dassow & Deets, LLC.

The NAACP, Cassandra Welch in her individual capacity, as well as Raynard Tyson, Sheryl A. Davis, Clara Walker, Delores Ryan, Allison Carter, Lawanda Rutledge, Joy Mason, Kelly French and Jackie Colbert are named as class representatives on behal
'/>"/>

SOURCE Sanford Wittels & Heisler, LLP
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Canary Foundation and Stanford University Commit $20 Million for World-Class Research Center for Cancer Early Detection
2. B. Braun Medical Wins Two GHX 2009 Best in Class Awards
3. Medical Bills Driving Most Middle-Class Bankruptcies
4. 1st Class Kids Host Miniature Golf Tournament to Raise Money in Support of Continued Obesity Research
5. DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm
6. GHX Announces 2009 Best In Class Award Winners
7. Elseviers PharmaPendium(TM) Introduces the FDA Classic Collection
8. Elseviers PharmaPendium introduces the FDA Classic Collection
9. Newborns of South Asian and East Asian descent misclassified as underweight at birth: Study
10. BREATHE 4 THE CURE Yoga Class Has Powerful Healing Impact on Breast Cancer Survivors, Family and Friends
11. World-Class Pediatric Orthopaedic Clinic Now Open for Kids

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... The American Academy o... care reform legislation released this week to con...e individual coverage mandate. The actuaries said ...imize adverse selection stemming from more restric.... ,, "The individual mandate language should be...
(Date:11/20/2009)...s and Congressmen in Competitive Re-election Battl... , Washington, DC (Vocus)...ning for re-election next year in races deemed to ... come to regret voting for House Speaker Nancy Pel...ing Zogby International/ O’Leary Report pol...
(Date:11/20/2009)... Centene Corporation (N...at the Bank of America Merrill Lynch 2009 Credit C...rowne Plaza Hotel Times Square in New York City. ,...at 8:30 a.m. Eastern Time. Investors and other int...f Centene,s presentation at: http://www.veracast....
(Date:11/20/2009)...ewswire-USNewswire/ -- The following is a statemen...da Health Care Association: ,, "The Nevada Heal...ate Majority Leader Harry Reid for his leadership ... of protecting every Nevada seniors, ongoing acces... strength and viability of our state,s vital front...
(Date:11/20/2009)...ormaldehyde used for embalming in the funeral indu...th from myeloid leukemia, according to a new study...he National Cancer Institute . , Previous studie...etic malignancies and brain cancer in anatomists, ... whom may have worked with formaldehyde. , For...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2
...n,(Nasdaq: MDTH ), a healthcare provider focused ...the diagnosis and treatment of cardiovascular,dise... first fiscal,quarter, which ended December 31, 20...). As part of the,recapitalization, MedCath,s owne...
...ploying,cross- functional, yet sufficiently specia...g leaders at pharmas and biotechs. However,best-in... similar,structure, composition, and responsibilit...have a core team of three,to 10 people and 86 perc...
...RAXIS Health Inc. (TSX:,DAX); (Nasdaq: DRAX ) rep...,the year ended December 31, 2007. Results for the...rter of 2006 were impacted by lower product sales,...th quarter of 2007 relative to the same quarter in...
...) Research Proves Dance Dance Revolut... Feb. 7 Based on the growing popularity of,video ... in favor of more,full-body interaction, the Ameri...sse, focused on quantifying DDR,s potential physic...
...asdaq: NUVO ) today announced that it will hold t...estor Conference February 13, 2008 11:45 a.m. ...ww.corporate-ir.net/ireye/conflobby.zhtml?ticker=N... ET (1:30 p.m. PT) Dr. Ted W. Love, Chairman and ...
...r and Health Advocates Together to Educate Co...SOUTHBOROUGH, Mass., Feb. 7 Most Americans are aw...id you know the Environmental,Protection Agency sa... out of 10 Americans are unaware of this fact,prim...
Other Medicine News:Health News:MedCath Corporation Reports First Quarter Earnings 2Health News:MedCath Corporation Reports First Quarter Earnings 3Health News:MedCath Corporation Reports First Quarter Earnings 4Health News:MedCath Corporation Reports First Quarter Earnings 5Health News:MedCath Corporation Reports First Quarter Earnings 6Health News:MedCath Corporation Reports First Quarter Earnings 7Health News:MedCath Corporation Reports First Quarter Earnings 8Health News:MedCath Corporation Reports First Quarter Earnings 9Health News:MedCath Corporation Reports First Quarter Earnings 10Health News:MedCath Corporation Reports First Quarter Earnings 11Health News:MedCath Corporation Reports First Quarter Earnings 12Health News:Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 3Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 4Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 5Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 6Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 7Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 8Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 9Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 10Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 11Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 12Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 13Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 14Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 15Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 16Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 17Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 18Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 19Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 20Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 21Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 22Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 23Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 24
(Date:11/20/2009)... , PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswir... Times article that questions why currently avail...e cancers are being ignored, ECRI Institute, an in...admap to the evidence on Finasteride for Preventi...The November 13, 2009, New York Times article, "...
(Date:11/20/2009)..., MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCa...dics Division is pleased to announce the signing o...d States Department of Defense that may lead to th...to revolutionize the treatment of the limbs of sol... year, the Defense Advanced Research Projects Agen...
(Date:11/19/2009)... , ARDEE, Ireland, Nov. 19 War...the pricing of its previously announced secondary ... price to the public of $22.25 per share. The sel...in Capital Partners, DLJ Merchant Banking, J.P. Mo... H. Lee Partners, L.P., certain other institutiona...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4CEM Wins Presidential Green Chemistry Challenge Award for the Sprint Rapid Protein Analyzer 12724 1CEM Wins Presidential Green Chemistry Challenge Award for the Sprint Rapid Protein Analyzer 12724 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 1KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 4KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 5KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 6 New Strategy Eyed for AIDS Treatment 49598 1 New Strategy Eyed for AIDS Treatment 49598 2
...itor, and R7128, nucleoside polymerase inhibitor, ...n patients with hepatitis C - , , NUTLEY, N.J., ...oche, InterMune, Inc. (Nasdaq: ITMN ) and Pharma...esults from their innovative, interferon-free regi...herapy for the treatment of patients chronically i...
...rmed to date will be presented during the Internat...nnual Meeting in Paris, France on April 24, 2009 ...d as an in vitro assessment of cell-mediated imm...erous clinical investigations have contributed to ...g recipients of solid organ transplants. , , (Lo...
Other Medicine Technology:Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 2Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 3Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 4Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 5Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 6Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 7Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 8Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 9Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 10Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 11An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients 2
Bipolar Bayonet Forceps
Elmed Extra Long Straight Bipolar Forceps
Micro Forceps
Bi-Co-Matic Handswitching Bipolar Micro Forceps with Elmed Fitting, Insulated
Medicine Products: